Relapsed Acute Myeloid Leukemia With Isolated Conjugated Hyperbilirubinemia Secondary to High-Dose Cytarabine Therapy

被引：0
|
作者：
Akpara, Ugochukwu [1 ]
Choi, Anthony J. [2 ]
Wan, David [3 ]
机构：
[1] New York Presbyterian Weill Cornell Med Ctr, Brooklyn, NY USA
[2] New York Presbyterian Weill Cornell Med Ctr, New York, NY USA
[3] Cornell Univ, Weill Cornell Med Coll, New York, NY 10021 USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2020年 / 115卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S2562
引用
收藏
页码：S1348 / S1348
页数：1
相关论文
共 50 条
  • [11] A randomized study of high-dose cytarabine in induction in acute myeloid leukemia
    Bishop, JF
    Matthews, JP
    Young, GA
    Szer, J
    Gillett, A
    Joshua, D
    Bradstock, K
    Enno, A
    Wolf, MM
    Fox, R
    Cobcroft, R
    Herrmann, R
    VanDerWeyden, M
    Lowenthal, RM
    Page, F
    Garson, OM
    Juneja, S
    BLOOD, 1996, 87 (05) : 1710 - 1717
  • [12] MITOZANTRONE AND HIGH-DOSE CYTARABINE IN ADULT ACUTE MYELOID-LEUKEMIA
    MARCUS, RE
    CATOVSKY, D
    GOLDMAN, JM
    GALTON, DAG
    NEWLAND, AC
    SLOCOMBE, G
    HEGDE, U
    LANCET, 1985, 1 (8442): : 1384 - 1384
  • [13] A multi-institutional comparison of mitoxantrone, etoposide, and cytarabine vs high-dose cytarabine and mitoxantrone therapy for patients with relapsed or refractory acute myeloid leukemia
    Christian, Sonia
    Arain, Saad
    Patel, Pritesh
    Khan, Irum
    Calip, Gregory S.
    Agrawal, Vaibhav
    Sweiss, Karen
    Griffin, Shawn
    Cahill, Kirk
    Konig, Heiko
    Esen, Aysenur
    Shergill, Ardaman
    Odenike, Olatoyosi
    Stock, Wendy
    Quigley, John G.
    AMERICAN JOURNAL OF HEMATOLOGY, 2020, 95 (08) : 937 - 943
  • [14] Efficacy of Antibiotics Prophylaxis after High-Dose Cytarabine Therapy in Pediatric Acute Myeloid Leukemia
    Matsui, Toshihiro
    Kato, Motohiro
    Miyairi, Isao
    Osumi, Tomoo
    Terashima, Keita
    Matsumoto, Kimikazu
    Tomizawa, Daisuke
    PEDIATRIC BLOOD & CANCER, 2020, 67
  • [15] INDUCTION THERAPY WITH HIGH-DOSE CYTARABINE AND ANTHRACYCLINES IN PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA
    Gil, Perez Angela
    Vazquez, Ramo Alejandro
    De Rojas, de Pablo Teresa
    Torralba, Gomez de Suso Miguel
    Nuevo, Lopez Irene
    Subira, Perez Dolores
    Merchan, Munoz Beatriz
    Perez, Ortega Alba
    De Miguel, Llorente Dunia
    HAEMATOLOGICA, 2020, 105 : 384 - 385
  • [16] Chemomodulation of sequential high-dose cytarabine by fludarabine in relapsed or refractory acute myeloid leukemia: a randomized trial of the AMLCG
    M Fiegl
    M Unterhalt
    W Kern
    J Braess
    K Spiekermann
    P Staib
    A Grüneisen
    B Wörmann
    D Schöndube
    H Serve
    A Reichle
    M Hentrich
    X Schiel
    C Sauerland
    A Heinecke
    C Rieger
    D Beelen
    W E Berdel
    T Büchner
    W Hiddemann
    Leukemia, 2014, 28 : 1001 - 1007
  • [17] Safety and activity of venetoclax in combination with high-dose cytarabine in children with relapsed or refractory acute myeloid leukemia.
    Karol, Seth E.
    Alexander, Thomas
    Das Gupta, Soumyasri
    Pounds, Stanley B.
    Canavera, Kristin
    Klco, Jeffery M.
    Lacayo, Norman James
    Pui, Ching-Hon
    Opferman, Joseph T.
    Rubnitz, Jeffrey E.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [18] Chemomodulation of sequential high-dose cytarabine by fludarabine in relapsed or refractory acute myeloid leukemia: a randomized trial of the AMLCG
    Fiegl, M.
    Unterhalt, M.
    Kern, W.
    Braess, J.
    Spiekermann, K.
    Staib, P.
    Grueneisen, A.
    Woermann, B.
    Schoendube, D.
    Serve, H.
    Reichle, A.
    Hentrich, M.
    Schiel, X.
    Sauerland, C.
    Heinecke, A.
    Rieger, C.
    Beelen, D.
    Berdel, W. E.
    Buechner, T.
    Hiddemann, W.
    LEUKEMIA, 2014, 28 (05) : 1001 - 1007
  • [19] Isolated hyperbilirubinemia following standard dose cytosine arabinoside in a patient with relapsed acute myeloid leukemia
    Altundag, O
    Altundag, K
    Celik, I
    Turker, A
    Kars, A
    AMERICAN JOURNAL OF HEMATOLOGY, 2004, 75 (04) : 263 - 264
  • [20] High-dose liposomal daunorubicin and high-dose cytarabine combination in patients with refractory or relapsed acute myelogenous leukemia
    Cortes, J
    Estey, E
    O'Brien, S
    Giles, F
    Shen, Y
    Koller, C
    Beran, M
    Thomas, D
    Keating, M
    Kantarjian, H
    CANCER, 2001, 92 (01) : 7 - 14
12345